Analysis of mutations across SARS-CoV2 genome from Gujarat may have a major contribution in the development of a single COVID-19 vaccine for the entire country, said Prof.
Chaitanya G. Joshi, Director at GBRC said NEW DELHI : Analysis of mutations across SARS-CoV2 genome from Gujarat would have a major contribution in the development of a single COVID-19 vaccine for the entire country, said Prof.
Chaitanya G. Joshi, Director at Gujarat Biotechnology Research Centre (GBRC). Gujarat has a total 17,200 confirmed cases and 1,063 deaths have been reported so far, second highest in the country after Maharashtra, which has reported 2,362 deaths so far.